Advances in our knowledge of the molecular characteristics of hepatocellular carcinoma
(HCC) have enabled significant progress in the detection and therapeutic prediction of HCC …

Solid tumors release a variety of cellular components into the bloodstream that can be
sampled by liquid biopsy. These blood-borne biomarkers include circulating tumor cells …

Liquid biopsies in cancer have received considerable attention as new biomarkers and
subjects of clinical translational research. Liquid biopsy-derived biomarkers, including …

Liver cancer incidence rate continues to increase and currently ranks third in the total
number of annual deaths, behind only lung and colorectal cancer. Most patients with …

Hepatocellular carcinoma (HCC) is the world's second leading cause of cancer death;
82.4% of patients die within 5 years. This grim prognosis is the consequence of a lack of …

Hepatocellular carcinoma (HCC) is the second leading cause of cancer‐related death
worldwide due to latent liver disease, late diagnosis, and nonresponse to systemic …

Simple Summary Hepatocellular carcinoma (HCC) is one of the mostly lethal cancers, with a
prognosis which is still very poor. Novel reliable biomarkers, useful in early diagnosis and …

Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer globally. Over 90%
of HCC cases arise in the context of liver cirrhosis, and the severity of the underlying liver …

Purpose We summarized the recent findings of liquid biopsy in cancer field and discussed
its potential utility in hepatocellular carcinoma. Methods Literature published in MEDLINE …

Simple Summary Hepatocellular carcinoma (HCC) is one of the deadliest cancer. Clinical
guidelines for the management of HCC endorse algorithms deriving from clinical variables …